Anxiety after coeliac disease diagnosis predicts mucosal healing: a population-based studyShow others and affiliations
2018 (English)In: Alimentary Pharmacology and Therapeutics, ISSN 0269-2813, E-ISSN 1365-2036, Vol. 48, no 10, p. 1091-1098Article in journal (Refereed) Published
Abstract [en]
Background: Coeliac disease has been linked to anxiety and depression. However, their association with mucosal healing is unknown.
Aim: To examine the relationship between anxiety, depression and mucosal healing in coeliac disease.
Methods: Between 1969 and 2008, we collected data on all small intestinal biopsies with villous atrophy from Sweden's 28 pathology departments. We restricted our cohort to individuals with data on follow-up biopsy (either persistent villous atrophy [n = 3317] or mucosal healing [n = 4331]). Through Cox regression, we estimated hazard ratios (HRs) for anxiety or depression.
Results: Conclusion APPENDIX During follow-up, 123 (2.8/1000 person-years) individuals with mucosal healing had developed anxiety, compared to 94 (2.1/1000 person-years) with persistent villous atrophy. Mucosal healing was hence associated with a higher risk of future anxiety (HR = 1.49; 95% CI = 1.12-1.96). Similarly, 167 (3.8/1000 person-years) individuals with mucosal healing developed depression, compared to 148 (3.3/1000 person-years) with persistent villous atrophy, corresponding to a HR of 1.25 (95% CI = 0.99-1.59). Mucosal healing was more common in individuals with prior diagnoses of anxiety or depression before follow-up biopsy. Anxiety diagnosed between diagnostic and follow-up biopsy for coeliac disease was associated with an almost nine-fold increased chance of mucosal healing (odds ratio = 8.94; 95%CI = 2.03-39.27).
Conclusion: Anxiety and depression are more common in coeliac disease patients with mucosal healing, both before and after follow-up biopsy, an association potentially mediated through more vigilant compliance with a gluten-free diet. This finding raises concern that achieving the goal of mucosal healing may come at a cost of an increased risk of mood disorders.
Place, publisher, year, edition, pages
John Wiley & Sons, 2018. Vol. 48, no 10, p. 1091-1098
National Category
Gastroenterology and Hepatology Pharmacology and Toxicology
Identifiers
URN: urn:nbn:se:oru:diva-70301DOI: 10.1111/apt.14991ISI: 000449555100005PubMedID: 30288774Scopus ID: 2-s2.0-85054488273OAI: oai:DiVA.org:oru-70301DiVA, id: diva2:1265406
Funder
The Karolinska Institutet's Research FoundationSwedish Research CouncilStockholm County Council
Note
Funding Agency:
Örebro University Hospital
2018-11-232018-11-232020-12-01Bibliographically approved